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Abstract 
Objectives: We review outcome studies regarding the effectiveness of hyperbaric oxygen 
therapy (HBOT) for Autism Spectrum Disorders (ASD). Method: Studies were identified 
through electronic bibliographic databases and manual searches of article reference lists.  
Results: A total of 8 studies met eligibility criteria, consisting of three randomized controlled 
trials (RCTs), one quasi-experimental study involving a comparison group, two pre-experimental 
one-group pretest–posttest studies, and two single-system designs. Studies reviewed did not offer 
credible evidence to suggest that HBOT is an effective treatment for autism. Conclusion: It is 
premature to call HBOT an effective treatment for Autism and ASD. Individuals clinically 
treated with HBOT outside the context of a RCT should have the effects of the therapy evaluated 
using rigorous single-subject designs. 
 
Keywords: Autism, Autism Spectrum Disorders, Autism Treatment, Hyperbaric Oxygen 
Therapy, HBOT   
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Is Hyperbaric Oxygen Therapy an Effective Treatment for Autism? A Review 
 
Autism Spectrum Disorder (ASD) is a diagnostic label used to categorize individuals 
with persistent deficits in social communication and interaction and also with various forms of 
restricted and repetitive behavior (APA, American Psychiatric Association, 2013, pp. 50-59).  
Specific examples of these behaviors include the failure of back and forth communication, 
abnormal eye contact, a lack of facial expression, and an absence of interest in peers, among 
others. The prevalence of ASD remains constant and may even be rising, effecting an estimated 
1% of the population (APA, 2013, p. 55). Males have been shown to be diagnosed with ASD 
more frequently than females, at a rate of 4.2:1 (Fombonne, 2009).   
  The etiology of autism remains unclear. Some have suggested a strong genetic 
component exists (Trottier, Srivastava, & Walker, 1999), but a definitive link to the disorder’s 
development has not been established clinically or etiologically (Miles, 2011). Proponents of this 
view have relied primarily on research utilizing twin and family studies and/or molecular 
genetics, but these methods have been plagued by problematic assumptions (e.g. the equal-
environment assumption) and a lack of replication (of autism-candidate genes) [For critiques of 
research utilizing twin and family studies, and on the genetic basis of psychiatric disorders, 
including autism, see Joseph, 2006, Ch. 7. on Autism]. Other etiological theories that are 
common yet remain unsupported, refuted, or unsettled include exposure to childhood 
vaccinations and mercury poisoning (Gerber & Offit, 2009; Wright, Pearce, Allgar, Miles, 
Whitton, Leon, Jardine, McCaffrey, Smith, Holbrook, Lewis, Goodall, & Alderson-Day, 2012; 
Geirer et al., 2008; Mrozek-Budzyn, Kieltyka, & Majewska, 2010; Roehr, 2013). Given the 
disorder’s unknown etiology, the road towards treating it remains equally varied and unclear.  
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Treatments have ranged across the spectrum, from applied behavior analysis (ABA) 
(Rosenwasser & Axelrod, 2001) to dietary interventions such as a gluten-free/casein-free 
regimen (Elder, Shankar, Shuster, Theriaque, Burns, & Sherrill 2006), and the use of 
antipsychotics such as risperidone (Purdon, Lit, LaBelle, & Jones, 1994). New and novel 
treatments are continuously proposed, including hyperbaric oxygen therapy (HBOT). 
Hyperbaric oxygen therapy is a treatment in which the patient breathes up to 100% 
oxygen in a pressurized environment. It is theorized that HBOT works by increasing atmospheric 
pressure, promoting the oxygenation of the blood via breathing this oxygen-enriched air, and 
thus blood flow and oxygenation in the brain is enhanced (Sharkey, 2000). Typically, treatments 
involve pressurization between 1.5 and 3.0 atmospheres absolute (ATA) for periods between 60 
and 120 minutes, once or twice daily. However, there have been no clear HBOT treatment 
guidelines for autism.   
Since finding success in treating decompression illness (Yarbough & Behnke, 1939), 
clinicians have proposed that HBOT could be a viable treatment for a wide variety of issues, 
including burns (Bilic et al., 2005), spinal cord injury (Asamoto, Suigiyama, Doi, Iida, Nagao, & 
Matsumoto, 2000), and other medical disorders (Gill & Bell, 2004). Rossignol and Rossignol 
(2006), two of the most active promoters of HBOT as a treatment for ASD, have suggested that 
autism is a neurodegenerative disorder, characterized by a lack of cerebral blood flow, 
neuroinflammation, and increased oxidative stress. They offered the following hypothesis on 
how hyperbaric therapy may alleviate some of the symptoms of autism:     
“HBOT helps overcome hypoperfusion, has potent anti-inflammatory effects and 
reduces oxidative stress. Furthermore, HBOT mobilizes stem cells from human bone 
marrow. Therefore, HBOT will improve symptoms of autism” (p. 217). 
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This view was supported by James Neubrander in his 2007 speech (Neubrander, 2007a) at the 
conference of the United States Autism and Asperger Association (USAAA), stating that “the 
following…irrefutably demonstrates from collective observations of over 250,000 treatment 
hours by my colleagues and me that hyperbaric oxygen therapy is a valuable treatment option for 
children with autism” (p. 1, emphasis added). He has also stated that in his clinic, "two of the 
most powerful treatments now commonly used for children on the autistic spectrum were 
discovered by accident - methylcobalamin (methyl-B12) and hyperbaric oxygen therapy. My 
presentation focuses on the use of oxygen under pressure as a powerful treatment modality for 
children on the spectrum...In my practice, approximately 80% of children respond to HBOT to 
some degree, especially if they continue their treatments....I have found that HBOT is a 
treatment, not a cure and continued treatment sets of sessions actually build upon any previous 
treatment sets of sessions therefore providing a cumulative beneficial effect...” (Neubrander, 
2007b, p. 2).   
 Here is how one father of a boy treated with HBOT described the treatment, in a 
newspaper article: 
 "HBOT's success is not only the ability to deliver more oxygen, but also to do so under 
 pressure. More oxygen without the pressure, the body simply can't absorb it. That's 
 because red blood cells, which transport oxygen throughout the body, are already doing 
 so at capacity. Pressurization enables the blood plasma, which makes up more than half 
 of blood, to deliver additional oxygen. For an autistic child, HBOT reactivates blood 
 vessels in the brain that have ceased functioning and reduces brain inflammation. ...The 
 Vitaeris 320...allows parent and child to enter the chamber together. Since it is a mild 
 oxygen-enriched environment, a parent and child can go into the chamber for 1.5 to 2 
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 hours. Once under pressure they are stuck there until someone else turns off the machine 
 and the pressure inside the HBOT is reduced to the pressure outside. Exiting the chamber 
 prematurely puts the person at risk of rupturing his or her eardrums. It takes oxygen from 
 the surrounding air, compresses it, and pumps it into the chamber where a mask can 
 direct the oxygen to the child. There is a wireless alarm bell inside that allows a parent to 
 signal to end the dive session. The user can bring toys and water inside. A viewing port 
 allows a two-way visual communication (Grundvig, 2007, p. 1).  
 Each treatment session is said to cost between $250 and $1000. The claims that the brains 
of autistic youth suffer from a lack of oxygen is merely a hypothesis and thus far there is no 
evidence to support it. The optimistic view of HBOT as a treatment for ASD is not shared by all 
hyperbarists. Some researchers (Yildiz, Aktas, & Uzun, 2008; Kot & Mathieu, 2011) are calling 
for more empirical evidence of HBOTs effectiveness, before establishing it as a viable treatment 
for ASDs. This is a necessary step before professional healthcare workers can ethically 
recommend HBOT as a treatment option for ASD. Fortunately, over the past decade, research on 
HBOT as a treatment for autism has grown, with some researchers calling for its widespread use.  
We conducted the following review evaluating and synthesizing the results of all the available 
outcome studies published in English, in peer-reviewed journals, in order to help answer the 
question: is hyperbaric oxygen therapy an effective treatment for autism?   
Method 
Electronic searches were used to identify relevant studies. Searches were made using the 
following bibliographic databases: PubMed, ASSIA: Applied Social Sciences Index and 
Abstracts, CINAHL, Cochrane Central Register of Controlled Trials (CENTRAL), Cochrane 
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Database of Systematic Reviews, PsycINFO, Social Services Abstracts, Database of Randomized 
Controlled Trials in Hyperbaric Medicine. Key words used in searching were: Hyperbaric 
Oxygen Therapy, Oxygen Therapy, HBOT, Hyperbaric Oxygenation, or Atmospheric Pressure 
AND Autism or Autism Spectrum Disorder. Located studies were initially screened based on 
their title and abstract. Studies were included if they met all of the following criteria: (a) a single-
system, pre-experimental, quasi-experimental, or experimental design was used to evaluate 
outcomes, (b) the study arrived at an autism or ASD diagnosis based on the DSM-III, DSM-IV. 
DSM-IV-TR, Autism Diagnostic Observation Scale (ADOS), Autism Diagnosis Interview 
(ADI), Autism Diagnostic Interview-Revised (ADI-R), or other standardized instrument that 
assess Autism or ASD symptomology, and have no other severe clinical disorder (e.g. Fragile X 
syndrome, cerebral palsy) or have suffered traumatic brain injury, (c) the study used hyperbaric 
oxygen therapy as a treatment for symptoms of autism or ASDs, (d) the study reported empirical 
outcome measures on any of three behavioral domains (social interaction, communication, 
behavior), (e) the study was published in English, and (f) the study was published in a peer-
reviewed journal. Studies were excluded if they did not report outcomes of treatment or provided 
only narrative or case reports. A search of the grey literature (conference papers, unpublished 
works, etc.) was not conducted. Hand searches were not performed, nor were attempts made to 
contact subject experts. Reference lists were searched for additional studies, but no studies 
meeting criteria were identified that had not been previously revealed through electronic 
searches. There were no year filters used during searches. 
Based on this approach, 39 studies were initially identified. After removing 8 duplicates, 
31 records were screened, applying the previously specified inclusion criteria. This resulted in 
the exclusion of 23 studies because they reported case reports or were not empirical studies. The 
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full-text of the 8 remaining articles was closely examined. All 8 studies are included in this 
review, consisting of three randomized-controlled trials (RCTs), one quasi-experimental study, 
two pre-experimental evaluations, and two single-system designs. A flow chart depicting the 
literature search process is displayed in Figure 1.  
Figure 1.  Flow Chart Depicting the Literature Search Process. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Records identified through 
database searching 
(n = 39) 
Additional records identified 
through other sources 
(n = 0) 
Records after duplicates removed 
(n = 31) 
Records screened 
(n = 31) 
Records excluded 
(n = 23) 
Full-text articles assessed 
for eligibility 
(n = 8) 
Full-text articles excluded, 
with reasons 
(n = 0) 
Studies included in 
qualitative synthesis 
(n = 8) 
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Results 
Study Characteristics: 
The studies reviewed included Rossignol et al. (2007), Chungpaibulpatana, 
Sumpatanarax, Thadakul, Chantharatreerat, Konkaew and Aroonlimsa (2008), Lerman, 
Sansbury, Hovanetz, Wolever, Garcia, O’Brien and Adedipe (2008), Granpeesheh, Tarbox, 
Dixon, Wilke, Allen and Bradstreet (2010), Rossignol et al. (2009), Bent, Bertoglio, Ashwood,, 
Nemeth, and Hendren (2012), Jepson et al. (2011) and Sampanthavivat, Singkhwa, Chaiyakul, 
Karoonyawanich and Ajpru, (2012). An overview of study characteristics is presented in Table 1.  
Table 1:  Features of Reviewed Studies 
Experimental and Quasi-Experimental Designs 
Study Intervention Study Population Study Design Outcomes  Results 
Sampanthav
-ivat et al. 
(2012) 
 
 
 
 
 
Granpeesheh 
et al. (2008) 
Real (n = 28)   
versus Sham 
(n = 28) 
HBOT 
 
 
 
 
HBOTa 
(n=16) vs. 
sham 
placebo 
(n=18) 
Children aged 3-
9 years, 
diagnosed with 
Autism 
 
 
 
 
Children ages 2-
14 w/Autistic 
Disorder. 
R O-X-O 
R O-X-O 
 
 
 
 
 
 
R O-X-O 
R O-X-O 
ATEC, CGI. 
CGIS 
 
 
 
 
 
 
ABC, BRIEF, 
CGI, PSI, 
PPVT-III, 
RBS, SRS, 
VABS-II, 
VMI-5, & 
direct 
observation. 
Both groups 
improved equally, 
leading to the 
conclusion that 
HBOT is a 
placebo-based 
treatment. 
 
Nine participants 
saw improvement 
on ADOS 
classifications in 
both groups. No 
significant 
differences in 
scores were 
reported on any 
other outcome 
measures. Both  
groups improved 
the same degree 
over time. 
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Study Intervention Study Population Study Design Outcomes  Results 
Rossignol et 
al. (2009) 
HBOTa 
(n=33) vs. 
sham 
placebo 
(n=29) 
Children ages 2- 
7 w/Autistic 
Disorder. 
 R O-X-O 
 R O-X-O 
ABC, ATEC, 
CGI 
Significant 
improvement 
within the 
hyperbaric group 
was observed 
across the domains 
of overall 
functioning, 
receptive language, 
social interaction, 
eye contact, and 
sensory/cognitive 
awareness, 
compared to 
participants in the 
control condition.  
      
Rossignol et 
al. (2007) 
HBOTa 
(n=12) vs. 
HBOTb 
(n=6) 
Children ages 3-
16 w/Autistic 
Disorder.  
O-X-O-O-O-O-O 
O-X-O-O-O-O-O 
ABC-C, SRS, 
and ATEC 
Improvements seen 
in both groups, 
across measures for 
irritability, social 
withdrawal, 
hyperactivity, 
motivation, speech, 
and 
sensory/cognitive 
awareness 
      
 
 
 
 
     
a-24% oxygen at 1.3 ATA  b-100% oxygen at 1.5ATA c-100% oxygen at 1.3 ATA  d-88% oxygen at 1.3 ATA 
Pre-Experimental Designs 
Study Intervention Study Population Study Design Outcomes Results 
Bent et al. 
(2011) 
HBOTb (n=10) Children 
ages 3-8 
w/ASD. 
      O-X-O-X-O 
 
ABC, PDD-BI, 
PIA-CV, 
PPVT, SB-V, 
and SB-NW 
Symptom 
improvement was 
seen in areas of the 
CGI-I, ABC, PDDBI, 
PIA-CV, PPVT. The 
Stanford-Binet 
however, did not 
corroborate these 
findings, showing no 
changes in non-
verbal or verbal 
intelligence. 
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Study Intervention Study Population Study Design Outcomes Results 
Chungpaibulpa
tana et al. 
(2008) 
HBOTc (n=7) Children 
ages 5-9 
w/ASD or 
Autistic 
Disorder. 
 O-X-O 
 
*Social 
development, 
Fine motor and 
hand-eye 
coordination, 
Language 
development, 
Gross-motor 
development, 
Self-help skills 
Improvements 
reported in 75% of 
participants. 25% of 
participants showed 
no improvement.  
33.34% of children 
showed improved 
sleeping habits, 
improvement in 
cognitive abilities, 
improved social 
skills, and increased 
flexibility in terms of 
problem solving.  
Parents corroborated 
these gains. 
      
 
 
     
a-24% oxygen at 1.3 ATA  b-100% oxygen at 1.5ATA c-100% oxygen at 1.3 ATA d-88% oxygen at 1.3 ATA 
*- did not disclose instruments used in assessing behavioral domains. 
Single-System Designs 
Study Intervention   Study Population  Study Design Outcomes         Results 
Lerman et 
al. (2008) 
HBOTd (n=3) 3 children, ages 
6-7 w/ Autism. 
A-B-A Task 
engagement, 
spontaneous 
communication, 
problematic 
behavior 
HBOT did not improve 
task engagement or 
decrease problematic 
behavior. Data on 
spontaneous 
communication showed 
improvement for one 
participant, but overall, 
no robust changes were 
found. 
      
Jepson 
(2011) 
HBOTa (n=16) Children ages 3-
10 w/ Autistic 
Disorder, PDD 
NOS, Asperger 
syndrome. 
A-B-A-A-
A 
ABC-C, SRS, 
ATEC, ADOS, 
BRIEF, CGI, 
PSI, PPVT-III, 
RBS, VABS-II, 
VMI-5, the 
Expressive 
Vocabulary Test, 
PDDBI, and SB-
5 
No consistent effect 
across any class of 
behavior was seen, nor 
was there a clear 
change seen for any 
individual behavior. 
      
a-24% oxygen at 1.3 ATA  b-100% oxygen at 1.5ATA c-100% oxygen at 1.3 ATA d-88% oxygen at 1.3 ATA 
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Various assessment measures were used to measure both patient functioning and 
outcomes across several domains. While some studies reported biological measures, only 
behavioral instruments and measurements will be presented in this review, given that the 
diagnosis of autism is arrived at solely by reviewing behavioral indicators. Behavioral measures 
included the Aberrant Behavior Checklist-Community (ABC-C), the Social Responsiveness 
Scale (SRS), the Autism Treatment Evaluation Checklist (ATEC), the Autism Diagnostic 
Observation Schedule (ADOS), the Behavior Rating Inventory of Executive Functioning 
(BRIEF), the Clinical Global Impression Scale (CGI), the Parent Stress Index (PSI), Peabody 
Picture Vocabulary Rest (PPVT-III), the Repetitive Behavior Scale (RBS), the Vineland 
Adaptive Behavior Scales-Second Edition (VABS-II), the Beery-Buktenica Developmental Test 
of Visual-Motor Integration-5th Edition (VMI-5), the Expressive Vocabulary Test, the Pervasive 
Developmental Disorder Behavior Inventory (PDDBI), and the Stanford-Benet-IV IQ test.   
One study (Lerman et al., 2008) directly observed and recorded behaviour across three 
primary domains: task engagement, spontaneous communication, and problem behavior. These 
domains were operationally defined before assessment of the intervention’s possible effects.  
Chungpaibulpatana, Sumpatanarax, Thadakul, Chantharatreerat, Konkaew, & Aroonlimsa (2008) 
also reported pre- and post-test measures of social development, fine motor and eye-hand 
coordination, language development, gross motor development, and self-help skills, but did not 
report the measures used. 
Study Outcomes: 
Randomized-Controlled Trials 
 Granpeesheh et al. (2010). The Granpeesheh et al. (2010) study included 34 youth (ages 
2-14) diagnosed with Autistic Disorder using DSM-IV criteria and corroborated with the ADOS.  
12
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These participants were recruited from a large community-based agency, which provided 
behavioral intervention services for children with ASDs. Originally, 46 children were recruited, 
but 12 were subsequently withdrawn from the study by their caregivers. The main reason for 
withdrawal was due to travel requirements for treatment. One of the 12 participants withdrew 
from the placebo group after having a seizure.  
 The 34 remaining participants were initially matched in pairs based on the amount of 
hours of behaviour-analytic treatment they had received up to the beginning of the study. These 
pairs were also matched based on age. Through use of a coin toss, pairs were randomly assigned 
to one of two groups, genuine hyperbaric oxygen therapy (n = 18) or placebo HBOT (n = 16).    
Both the hyperbaric therapy and the placebo consisted of 80 1-hour sessions in a HBOT 
chamber. Participants were to complete the 80 sessions within 15 weeks or less, with a range of 
6-10 sessions in the hyperbaric chamber per week. The difference between the two conditions 
was that the HBOT group received 24% oxygen at 1.3 ATA, while the placebo group received 
free airflow through the chamber at ambient pressure. Investigators, assessors, and the patients’ 
caregivers were blind to the clients' treatment condition. 
 Outcome measures included the ABC, BRIEF, CGI, PSI, PPVT-III, RBS, SRS, VABS-II, 
and VMI-5. The ASOD, BRIEF, PPVT-III, SRS, VABS, and VMI-5 were administered pre and 
post-treatment, while the ABC, CGI, and RBS were administered weekly. The PSI was 
administered four times, once at baseline, twice during the treatment phase, and once at the 
completion of the study. The authors also utilized direct observation, twice weekly, using 
standard functional analysis of “Toy Play.” Trained observers collected data on toy play, 
hyperactivity, appropriate vocalizations, vocal stereotypy, physical stereotypy, and challenging 
behaviors. Observers were blind to assignment, and observational assessments were subject to 
13
Dunleavy and Thyer: HBOT for Autism
Published by UTC Scholar, 2014
IS HYPERBARIC OXYGEN THERAPY AN EFFECTIVE TREATMENT FOR AUTISM?    14 
 
interobserver agreement (IOA) in at least 30% of observations for each participant. Mean 
agreement among observers was 80% or higher for each participant.  
 Both groups improved over time, but there were no differences in the degree of 
improvement between conditions, leading the authors to conclude that HBOT had no genuine 
therapeutic effect. This study strongly illustrates the need to compare the results obtained via real 
HBOT to a credible placebo treatment, preferably a blinded sham HBOT condition. Solely 
examining the results of patients treated with real HBOT may give the appearance of 
improvement attributable to the treatment, and give both clinicians and family members 
observing these “improvements” a false sense of therapeutic benefit. Thus uncontrolled studies 
may be virtually useless in determining the real effects of HBOT above and beyond placebo 
factors.    
Rossignol et al. (2009). This Rossignol et al. study initially consisted of 62 participants 
(ages 2-7) who met DSM-IV criteria for autism, which was corroborated by the ADI-R and 
ADOS. Potential participants were excluded if they had met the criteria for Pervasive 
Developmental Disorder - Not Otherwise Specified (PDD-NOS), asperger syndrome, seizure 
disorder, current ear infection, uncontrolled asthma, Fragile X syndrome, had trouble equalizing 
ear pressure, or were receiving ongoing treatment using chelation therapy.   
 The 62 children were randomly assigned to one of two groups, HBOT (33 children) or 
“near-placebo” hyperbaric conditions (29 children). Both conditions provided 40 1-hour 
treatment sessions, twice daily, with a minimum of 4 hours between treatments.  This was done 
for 5 days a week, for 4 consecutive weeks, totalling 40 treatments per participant. Hyperbaric 
treatment involved breathing 24% oxygen at 1.3 ATA. The placebo control condition involved 
breathing 21% oxygen at 1.03 ATA (e.g. near normal air). Four children in the HBOT group 
14
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dropped out of treatment, whereas three children dropped out of the control group. Of the HBOT 
dropouts, two were due to illness, one due to parental and child anxiety, and one due to 
worsening asthma symptoms. In the control condition, one child dropped out due to a family 
death, another due to travel commitments, and one due to parental claustrophobia. 29 children 
completed the study in the hyperbaric condition and 26 in the sham HBOT condition. Allocation 
was concealed to everyone involved (investigators, participants, parents, clinic staff, nursing 
staff, etc.), with the exception of the hyperbaric technician.   
 Outcome measures assessed change from baseline to post-treatment. The ABC, ATEC, 
and CGI scales were rated by parents or guardians and separately by the treating physician. 
Significant improvement within the hyperbaric group was observed across the domains of overall 
functioning, receptive language, social interaction, eye contact, and sensory/cognitive awareness, 
compared to participants in the placebo control condition. These positive results have been 
criticized by other researchers in the field. Bent et al. (2012) noted that while this study reported 
improvement on the CGI-I for participants in the hyperbaric condition, improvements in other 
outcome measures, such as the ABC scale, were not reported. Jepson et al. (2010) point out that 
statistically significant outcomes were found in the sensory/cognitive subscale of the ATEC, but 
not others. Likewise, it is pointed out that the ATEC has not been validated by the scientific 
community for use in this type of study. The Rossignol et al. (2009) study was also criticized for 
not collecting pre-treatment reports of the CGI, which prohibits pre-post effect ratings.  Also, 
physicians did not complete the entire CGI, instead focusing on only one item of the instrument
 Sampanthavivat et al. (2012) randomly assigned 60 Thai children with a diagnosis of 
Autism to 20 one-hour sessions of HBOT. The children were aged 3-9 years. The experimental 
group received 1.5 ATA with 100% oxygen for 20 one-hour sessions conducted over weekdays.  
15
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The placebo control group received sham HBOT, experiencing exactly the same procedures as 
did the experimental group, except they breathed a normal air mixture maintained at 1.15 ATA, a 
level of air pressure needed to keep the door to the chamber tightly closed and to convey 
sensations of increased pressure. Children were accompanied by a parent or other caregiver 
during their HBOT sessions. The primary outcome measures were the Autism Treatment 
Evaluation Checklist, and the Clinical Global Impression scale, given one-time pre and post-
HBOT. Patients and their families did not know which treatment they were receiving, real HBOT 
or sham HBOT, and neither did the assessors. Thus the study was a double-blind trial. Initial 
outcome measure scores did not differ between the two groups pre-treatment. Post-treatment, the 
real HBOT group demonstrated statistically significant improvements on the outcome measures, 
but these were matched by similar improvements among the parents whose children received 
sham HBOT. The authors concluded that "HBOT conferred no benefit above that owing to a 
participation (or placebo) effect...Considerably more evidence is needed before accepting there is 
a true rationale to support the routine use of low-pressure hyperbaric treatment in order to 
improve behavior in children with autism...we cannot recommend the routine use of HBOT in 
this regard" (Sampanthavivat et al. 2013, p. 131, 131, 132). 
 
Quasi-Experimental Designs 
Rossignol  et al. (2007). This study consisted of 18 participants (ages 3-16) diagnosed 
with autism by an independent mental health professional. Two groups of children were formed 
from the four girls and fourteen boys, using nonrandomized methods. One group (N = 12), 1 girl) 
received HBOT at 1.3 ATA and 24% oxygen, while the other group (N = 6, 3 girls) received 
HBOT at 1.5 ATA and 100% oxygen (e.g., two different forms of 'real' HBOT). Both groups 
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were given HBOT for 45 minutes a session, for 40 treatments per child. The group receiving 
24% oxygen averaged 4.6 sessions per week over a 9-week period and the group receiving 100% 
oxygen averaged 4.7 treatments over an 8.8-week period. All 18 children were able to complete 
the 40 hyperbaric sessions.   
    Behavioral outcome measures included pre-treatment and post-treatment scores of the 
ABC-C, SRS, and ATEC. Parents or guardians, who were not blinded, filled out each scale prior 
to treatment, and after 10, 20, 30, and 40 treatment sessions. The authors reported improvements 
in both groups, across measures for irritability, social withdrawal, hyperactivity, motivation, 
speech, and sensory/cognitive awareness. The authors note, however, that this data is limited by 
a lack of assessor blinding, a lack of placebo or control group, non-random assignment to 
conditions, and the possibility that chance or natural development of the children influenced the 
outcomes. 
Pre-Experimental Designs 
 Bent et al. (2012). This Bent et al. study examined the effects of HBOT on one group of 
10 children, recruited from an outpatient autism clinic.  The children ranged in age from 3 to 8 
years, and had a DSM-IV diagnosis of ASD, corroborated by the ADOS and the SCW.   
 Treatment consisted of all participants receiving HBOT at 1.5 ATA and 100% oxygen.  
Participants received a total of 80 treatment sessions over the course of 20 weeks. 40 treatment 
sessions were given over the course of 8 weeks, followed by a 4-week break, followed by 
another 40 treatment sessions over an 8 week period. Children were assessed pre-treatment, after 
40 days, and after 80 days of treatment. Outcome measures used included the ABC, PDD-BI, 
PIA-CV, PPVT, SB-V, and SB-NW. Guardians completed the ABC and PDDBI. Clinicians 
rated and scored the CGI-I, based on parent interviews and direct clinical observation. The 
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authors reported marked improvement in symptoms for parent-reported measures. Symptom 
improvement was seen in areas of the CGI-I related to imitation, eye contact, language, eczema, 
gastrointestinal problems, and severity/frequency of tantrums. Scores on the ABC showed 
improvement in irritability, lethargy, hyperactivity, and total score. The PDDBI showed 
statistically significant improvements across three of ten subscales. The PIA-CV showed 
improvement in terms of language, intelligence, while the PPVT showed improvement in 
receptive vocabulary. The Stanford-Binet however, did not corroborate these findings, showing 
no changes in non-verbal or verbal intelligence. The authors caution that these outcomes relied 
heavily on parent reported measures, and that reporting may be influenced by parental bias or the 
placebo effect. Due to the small sample size, weak methodology (being a one group, pre-test 
post-test design lacking any comparison groups), and reliance on parent reported outcomes, it is 
not possible to definitively say whether HBOT was responsible for any improvements reported at 
the conclusion of treatment.      
 Chungpaibulpatana et al. (2008).  This study examined the effects of HBOT on seven 
Thai children (ages 5-9) who had a DSM diagnosis of ASD or Autistic Disorder. Treatment 
involved HBOT at 1.3ATA and 100% oxygen given once a week for 10 weeks. Assessment 
measures were taken pre and post-treatment.     
 The study measured changes across five domains: 1) Social development, 2) Fine motor 
and hand-eye coordination, 3) Language development, 4) Gross-motor development, and 5) Self-
help skills. Scales used in assessment were not disclosed. The authors reported statistically 
significant improvements across all five domains with 75% of participants having positive 
outcomes and 25% not improving. 33.34% of children showed improved sleeping habits, 
improvement in cognitive abilities, improved social skills, and increased flexibility in terms of 
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problem solving. These gains were corroborated by parents, but the findings are limited in 
several ways.  First, the study lacked a comparison or no-treatment group, which prevents the 
authors from concluding that HBOT was responsible for the changes witnessed in the children.  
Second, subjective responses from children and parents may have been influenced by the placebo 
effect or by reporting bias. Lastly, the clinical significance of the data cannot be determined due 
to the study’s small sample size and the authors' limited description of outcome measures.         
Single-System Designs 
 Lerman et al. (2008).  This study examined the effects of HBOT given to three children 
diagnosed with Autism. The participants were two 6-year-old boys and one 7-year-old girl. 
HBOT was given in 60-minute sessions, for a total of 40 sessions, at 88% oxygen and 1.3 ATA.   
Ultimately, the two boys completed 40 sessions of treatment and the girl completed 27 sessions 
before stopping due to the development of an unrelated eye infection.   
A non-concurrent multiple-baseline design across participants was utilized for the study.  
The first participant was measured at baseline for a minimum of 20 days before treatment. The 
second participant received treatment after 40 days of baseline and the third received treatment 
after 60 days.             
Participants were videotaped three times a week, during 10-minute instructional session 
given at the center. Data software was utilized to score child and therapist responses, by 
observers who were blind to the study’s purpose and to the timing of the intervention.  
Participant behavior was measured in terms of the frequency of unprompted task engagement 
and the frequency of spontaneous communication and problem behavior. The results suggest that 
HBOT did not improve task engagement or decrease problematic behavior. Data on spontaneous 
communication was inconclusive (with one participant showing improvement for this measure), 
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but overall, no clinically meaningful behavioral improvements were found. A strength of this 
study is that detailed and reliable measures of the children's functioning were repeatedly assessed 
before and after the use of HBOT. To the extent that HBOT is claimed to yield improvements in 
behavior among youth with autism, this hypothesis was falsified in this intensive study. 
Jepson et al. (2011). This study directly observed the behaviors of 16 children (ages 3-
10) diagnosed with Autistic Disorder, PDD NOS, or Asperger’s syndrome. Participants were 
assessed prior to treatment using the ADOS, the Wechsler Preschool and Primary Intelligence-III 
or the Wechsler Abbreviated Scale of Intelligence, the Vineland Adaptive Behavior Scale-II, and 
the ABC.   
This study used a non-concurrent multiple-baseline design, across participants. Treatment 
consisted of 40 sessions of HBOT at 24% oxygen and 1.3 ATA, for 60 minutes, conducted over 
an average of 8 weeks. Participants were followed up at 2 weeks after the last HBOT session and 
at the 3-month mark, for observational play sessions. These sessions were used to gather data 
across 11 operationally defined behaviors.  
 The behavioral observations results were recorded in three classes: 1) adaptive behavior 
(vocal initiations, physical initiations, vocal response, and physical response), 2) stereotypy 
(vocal and physical stereotypy), and 3) aberrant behavior (rate of aggression, self-injurious 
behavior, tantrums, and disruption).  The authors concluded: "Multiple topographies of behavior 
were measured under carefully controlled conditions and no consistent effects (positive or 
negative) were observed. Based on these results, there is no compelling evidence to suggest that 
HBOT, delivered at 24% oxygen and 1.3 ATA, is an effective treatment modality for the core 
behavior symptoms of Autism" (Jepson et al., 2011, p. 583). 
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Discussion 
 Of the eight studies included in this review, four (Granpeesheh et al., 2010; Bent et al., 
2012; Lerman et al., 2008; Jepson et al., 2011) suggested that HBOT might not be an effective 
treatment for the behavioral symptoms of Autism and ASDs. The remaining three studies 
(Rossignol et al., 2009; Rossignol et al., 2007; Chungpaibulpa et al., 2008) suggested that HBOT 
might help decrease some behavioral symptoms associated with Autism and ASDS. The data 
gathered from these eight studies is limited by small sample sizes (214 total participants), a lack 
of rigorous study designs, a reliance on parent-rated assessments, and a lack of comparison, 
placebo, and no-treatment groups. These limitations could be remedied through the use of a 
large, multi-armed, double-blinded randomized control trial that compares different types of 
hyperbaric treatment with placebo and no treatment conditions. While this has been attempted by 
Granpeesheh et al. and Rossignol et al. (2009), several issues have risen. Granpeesheh et al. were 
lacking a no-treatment group and relied heavily on parent-rated assessments, which left open the 
possibility of parental bias.  The Rossignol study also relied heavily on these assessments and 
has been criticized by other hyperbaric researchers (Bent et al.; Jepson et al.) for faulty data 
interpretation and usage. 
 It remains to be seen if hyperbaric therapy can alleviate some of the symptoms of autism.  
The three strongest designs to date, Lerman et al., (2008), Jepson et al. (2011) and 
Sampanthavivat et al. (2013), suggest that it does not. The current evidence reviewed does not 
support hyperbaric oxygen therapy as an effective treatment for autism or Autism Spectrum 
Disorders. Clinicians have the responsibility to offer safe as well as empirically supported 
treatments. Currently, it is premature to call HBOT an efficacious treatment and the available 
evidence suggests that the limited positive changes following its application are most 
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parsimoniously explained as placebo effects. Support of more rigorous trials, especially large-
scale RCTs, with valid control and comparison groups, and proper blinding and assessment tools, 
are required before HBOT can be recommended as an option for those with autism and ASD.  
Persons who receive HBOT as a clinical treatment, outside of the context of a well-designed 
RCT, should have the effects of their therapy carefully evaluated using an experimental single 
subject research design.  
 We note the principles enunciated in the American Medical Association's Code of Ethics, 
reading: 
"The following general guidelines are offered to serve physicians when they are called upon 
to decide among treatments: 
(1) Treatments which have no medical indication and offer no possible benefit to the patient 
should not be used. 
(2) Treatments which have been determined scientifically to be invalid should not be used 
 (4) Among the various treatments that are scientifically valid, medically indicated, legal, and 
offer a reasonable chance of benefit for patients, the decision of which treatment to use should be 
made between the physician and patient." (American Medical Association's Code of Ethics, 
downloaded from http://www.ama-assn.org/ama/pub/physician-resources/medical-ethics/code-
medical-ethics.page? on 27 March 2013, emphases added) 
 Individuals and families seeking accurate and up-to-date information about the scientific 
status of various therapies for autism may consult a summary of the evidence on these treatments 
to be found at http://www.asatonline.org/treatment/treatments_desc, a website maintained by the 
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Association for Science in Autism Treatment, as well as Offit (2010) and Thyer & Pignotti 
(2010). Until better evidence accrues through carefully controlled evaluations, individuals with 
Autistic Spectrum Disorders should not be subjected to expensive sessions of HBOT. 
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